Volker Diehl

49.2k total citations · 11 hit papers
696 papers, 31.2k citations indexed

About

Volker Diehl is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Volker Diehl has authored 696 papers receiving a total of 31.2k indexed citations (citations by other indexed papers that have themselves been cited), including 396 papers in Pathology and Forensic Medicine, 222 papers in Oncology and 194 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Volker Diehl's work include Lymphoma Diagnosis and Treatment (390 papers), Lung Cancer Treatments and Mutations (175 papers) and Chronic Lymphocytic Leukemia Research (136 papers). Volker Diehl is often cited by papers focused on Lymphoma Diagnosis and Treatment (390 papers), Lung Cancer Treatments and Mutations (175 papers) and Chronic Lymphocytic Leukemia Research (136 papers). Volker Diehl collaborates with scholars based in Germany, United States and Switzerland. Volker Diehl's co-authors include Andreas Engert, Gertrude Henle, Werner Henle, Hans Tesch, Andreas Josting, Beate Pfistner, Jeremy Franklin, Hartmut Kirchner, Dirk Hasenclever and M. Schaadt and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Volker Diehl

679 papers receiving 29.9k citations

Hit Papers

Revised Response Criteria ... 1967 2026 1986 2006 2007 1968 2002 1998 1982 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revised Response Criteria for Malignant Lymphoma
    2007 3.2k citations Volker Diehl et al. Journal of Clinical Oncology profile →
  2. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.
    1968 904 citations Volker Diehl et al. profile →
  3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
    2002 755 citations Andreas Lohri, Dirk Hasenclever et al. profile →
  4. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
    1998 724 citations Andreas Engert, Volker Diehl et al. profile →
  5. Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
    1982 720 citations Ulrich Schwab, Johannes Gerdes et al. profile →
  6. Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
    2003 538 citations Volker Diehl, Jeremy Franklin et al. profile →
  7. Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)
    1999 516 citations Oliver Manzke, H. Schulz et al. profile →
  8. Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells
    1967 465 citations Volker Diehl et al. profile →
  9. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma
    1982 374 citations Volker Diehl et al. profile →
  10. Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups<xref ref-type="fn" rid="FN2">2</xref>
    1969 347 citations Volker Diehl et al. profile →
  11. Antibodies to Epstein-Barr Virus in Nasopharyngeal Carcinoma, Other Head and Neck Neoplasms, and Control Groups<xref ref-type="fn" rid="FN2">2</xref>
    1970 341 citations Volker Diehl et al. profile →

Peers

Volker Diehl
Richard I. Fisher United States
Fernando Cabanillas United States
Jamés O. Armitage United States
Stefano Pileri Italy
Gilles Salles France
Andreas Engert Germany
Thomas E. Witzig United States
L. Jeffrey Medeiros United States
Elaine S. Jaffe United States
Luis A. Díaz United States
Richard I. Fisher United States
Volker Diehl
Citations per year, relative to Volker Diehl Volker Diehl (= 1×) peers Richard I. Fisher

Countries citing papers authored by Volker Diehl

Since Specialization
Citations

This map shows the geographic impact of Volker Diehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Diehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Diehl more than expected).

Fields of papers citing papers by Volker Diehl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Diehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Diehl. The network helps show where Volker Diehl may publish in the future.

Co-authorship network of co-authors of Volker Diehl

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Diehl. A scholar is included among the top collaborators of Volker Diehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Diehl. Volker Diehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasse, Stephanie, Beate Klimm, Helen Görgen, et al.. (2012). Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Annals of Oncology. 23(11). 2953–2959. 25 indexed citations
2.
Behringer, Karolin, Indra Thielen, Horst Mueller, et al.. (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of Oncology. 23(7). 1818–1825. 63 indexed citations
3.
Engert, Andreas, Volker Diehl, Jeremy Franklin, et al.. (2009). Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study. Journal of Clinical Oncology. 27(27). 4548–4554. 303 indexed citations
4.
Thiele, Jürgen, Hans Michael Kvasnicka, & Volker Diehl. (2005). Initial (Latent) Polycythemia vera with Thrombocytosis Mimicking Essential Thrombocythemia. Acta Haematologica. 113(4). 213–219. 54 indexed citations
5.
Reineke, Thorsten, Andreas Josting, Hans Konrad Müller‐Hermelink, et al.. (2005). Lymphocyte‐predominant and classical Hodgkin's lymphoma – comparison of outcomes. European Journal Of Haematology. 75(s66). 106–110. 20 indexed citations
6.
Eich, Hans‐Theodor, Uwe Haverkamp, Andreas Engert, et al.. (2004). Biophysical analysis of acute toxicity of radiotherapy in Hodgkin’s lymphoma — a comparison between extended field and involved field radiotherapy based on the data of the german hodgkin study group (GHSG). International Journal of Radiation Oncology*Biology*Physics. 60(1). S219–S219.
7.
Reiser, Marcel, Stefan Barth, Peter Borchmann, et al.. (2002). Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. Annals of Hematology. 81(5). 258–266. 15 indexed citations
8.
Thiele, Jüergen, Hans Michael Kvasnicka, Annette Schmitt‐Graeff, et al.. (2001). Therapy-Related Changes of CD34 + Progenitor Cells in Chronic Myeloid Leukemia: A Morphometric Study on Sequential Trephine Biopsies. Journal of Hematotherapy & Stem Cell Research. 10(6). 827–836. 2 indexed citations
9.
Thiele, Jürgen, et al.. (2001). The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.. PubMed. 86(4). 368–74. 37 indexed citations
10.
Reiser, Marcel, Andreas Josting, Volker Diehl, & Andreas Engert. (2001). Primary lymphoma of the conjunctiva - a rare manifestation of indolent non-Hodgkin's lymphoma. Annals of Hematology. 80(5). 311–313. 2 indexed citations
11.
Franzen, Caspar, Axel H. E. Müller, Ralf Bialek, et al.. (2000). Taxonomic position of the human intestinal protozoan parasite Isospora belli as based on ribosomal RNA sequences. Parasitology Research. 86(8). 669–676. 23 indexed citations
12.
Manzke, Oliver, Kevin Fitzgerald, Philipp Holliger, et al.. (1999). CD3� anti-nitrophenyl bispecific diabodies: Universal immunotherapeutic tools for retargeting T cells to tumors. International Journal of Cancer. 82(5). 700–708. 12 indexed citations
13.
Diehl, Volker, et al.. (1998). Die Therapie des Morbus Hodgkin. Der Internist. 39(9). 917–926. 1 indexed citations
14.
Knethen, Andreas von, Harry F. Abts, Dieter Kube, Volker Diehl, & Hans Tesch. (1997). Expression of p56 lck in B-Cell Neoplasias. Leukemia & lymphoma. 26(5-6). 551–562. 19 indexed citations
15.
16.
Trümper, Lorenz, et al.. (1994). Intensification of the CHOEP Regimen for High-Grade Non- Hodgkin’s Lymphoma by G-CSF: Feasibility of a 14-Day Regimen. Oncology Research and Treatment. 17(1). 69–71. 10 indexed citations
17.
Kalle, Christof von & Volker Diehl. (1992). Hodgkin's Disease: Analysis of Cell Line Data. PubMed. 33. 185–203. 3 indexed citations
18.
Hiller, Erhard, H. Gerhartz, Markus Löffler, et al.. (1991). Ergebnisse und therapeutische Konsequenzen der Staging Laparotomie beim Morbus Hodgkin. Oncology Research and Treatment. 14(2). 171–177. 4 indexed citations
19.
Diehl, Volker, et al.. (1986). Hodgkin's disease in adults preliminary results of the hd 1 hd 2 and hd 3 trials. Journal of Cancer Research and Clinical Oncology. 111. 6. 1 indexed citations
20.
Stein, H, Johannes Gerdes, Ulrich Schwab, Hilmar Lemke, & Volker Diehl. (1983). Evidence for the Origin of Hodgkin and Sternberg-Reed Cells from a Newly Detected Small Cell Population. Hämatologie und Bluttransfusion. 28. 407–410. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard I. Fisher Breakdown of academic impact, for papers by Fernando Cabanillas Breakdown of academic impact, for papers by Jamés O. Armitage Breakdown of academic impact, for papers by Stefano Pileri Breakdown of academic impact, for papers by Gilles Salles Breakdown of academic impact, for papers by Andreas Engert Breakdown of academic impact, for papers by Thomas E. Witzig Breakdown of academic impact, for papers by L. Jeffrey Medeiros Breakdown of academic impact, for papers by Elaine S. Jaffe Breakdown of academic impact, for papers by Luis A. Díaz
Rankless by CCL
2026